EXOZ eXoZymes, Inc.
Healthcare$9.92+5.53%ClosedMarket Cap: $84.1M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
54.91
P/S
0.00
EV/EBITDA
-8.50
DCF Value
$0.14
FCF Yield
-8.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-220.6%
ROA
-240.7%
ROIC
-362.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $-2.4M | $— |
| Q4 null | $0.00 | $-2.7M | $— |
| FY null | $0.00 | $-9.2M | $— |
| Q3 null | $0.00 | $-2.3M | $— |
Trading Activity
Insider Trades
View AllKorman Tyler Pazofficer: Chief Scientific Officer
SellFri Apr 10
Perriman Damien Alanofficer: Chief Commercial Officer
SellWed Apr 08
Perriman Damien Alanofficer: Chief Commercial Officer
SellWed Apr 08
Perriman Damien Alanofficer: Chief Commercial Officer
SellWed Apr 08
Perriman Damien Alanofficer
SellWed Apr 08
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
2.86
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.